News
A condition that can impact women’s fertility and diabetes risk goes undiagnosed in many cases, but experts hope giving it a new name will help more patients receive care.
- May 13, 2026
The inaugural symposium for the Yale Biological Imaging Institute (YBII) will be held on June 12, 2026, in the Harkness Auditorium.
- May 12, 2026Source: Journal of Addiction Medicine
Oluwole Jegede, MD, PhD; Henrique Oliva, MD, PhD; and Gustavo A. Angarita, MD, MHS, are co-first and senior authors, respectively, of a paper in Journal of Addiction Medicine that examines treatment outcomes associated with contingency management for individuals with stimulant-opioid co-use.
- May 07, 2026Source: Radiological Society of North America News
The Radiological Society of North America News features Julius Chapiro, MD, PhD, is an associate professor of radiology and biomedical engineering at Yale School of Medicine.
- May 07, 2026
Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and professor of psychiatry, and in the Child Study Center and of radiology and biomedical imaging, has been elected to serve a second term as Councilor of The International College of Neuropsychopharmacology.
- May 06, 2026Source: JAMA Psychiatry
A systematic review and meta-analysis of 26 randomized clinical trials with 1,166 patients with a major depressive episode found that ketamine was efficacious in reducing suicidal and depressive symptoms rapidly, within hours. Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of the paper, published in JAMA Psychiatry.
- May 06, 2026
Eighteen faculty members of the Department of Radiology and Biomedical Imaging are among the “Top Doctors,” according to Connecticut Magazine’s 2026 list.
- May 05, 2026
Stefan Somlo, MD, was elected to the National Academy of Sciences in recognition of his distinguished and continuing achievement in original research related to inherited human kidney diseases.
- May 05, 2026Source: Front Row: Live from Stage IV Podcast
The conversation moves through the clinical landscape with rare clarity. Dr. Winer walks through three trials — CLEOPATRA, PATINA, and DESTINY-Breast09 — not as a dry literature review, but as building blocks of an evolving argument: that for some patients with HER2-positive metastatic breast cancer, long-term remission achieved through standard therapy isn't just possible. It's already happening.
- May 01, 2026
List of 119 Yale Cancer Center physicians named as 2026 'Top Doctors'